Fuse Medical, Inc. (FZMD) financial statements (2021 and earlier)

Company profile

Business Address 1565 NORTH CENTRAL EXPRESSWAY
RICHARDSON, TX 75080
State of Incorp. DE
Fiscal Year End December 31
SIC 5047 - Medical, Dental, and Hospital Equipment and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,1871,5391,1677531,0991,031842
Cash and cash equivalents1,1871,5391,1677531,0991,031842
Receivables4,4283,2152,9874,4146,1744,7593,911
Inventory, net of allowances, customer advances and progress billings6,9816,9837,0527,8027,8568,19010,766
Inventory6,9816,9837,0527,8027,8568,19010,766
Other undisclosed current assets243588117401719
Total current assets:12,62111,77211,29413,08715,16913,99715,537
Noncurrent Assets
Property, plant and equipment18253344332732
Long-term investments and receivables, including:1,6702,0701,831    
Other undisclosed long-term investments and receivables1,6702,0701,831    
Intangible assets, net (including goodwill)3,1113,1243,1393,1593,1804,1324,152
Goodwill1,9731,9731,9731,9731,9732,9052,905
Intangible assets, net (excluding goodwill)1,1381,1511,1661,1861,2071,2271,247
Other undisclosed noncurrent assets      930
Total noncurrent assets:4,7985,2195,0033,2033,2124,1595,114
TOTAL ASSETS:17,41916,99016,29716,29018,38118,15720,652
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,8215,8655,3045,3356,0565,4364,355
Accounts payable3,2372,3432,2402,5722,7532,5262,395
Accrued liabilities2,5853,5223,0652,7633,3032,9101,961
Debt9131,0381,0881,5031,7531,7531,253
Due to related parties150150150150150150150
Other undisclosed current liabilities364361361    
Total current liabilities:7,2487,4156,9046,9887,9587,3385,758
Noncurrent Liabilities
Liabilities, other than long-term debt12,13611,84511,84511,64511,64513,58213,582
Due to related parties200200200    
Business combination, contingent consideration, liability11,93611,64511,64511,64511,64513,58213,582
Other undisclosed noncurrent liabilities148150150    
Total noncurrent liabilities:12,28411,99511,99511,64511,64513,58213,582
Total liabilities:19,53219,41118,89918,63319,60420,92019,339
Stockholders' equity
Stockholders' equity attributable to parent(2,113)(2,420)(2,602)(2,343)(1,222)(2,763)1,313
Common stock731731731731731715715
Additional paid in capital1,1841,071970805642488499
Retained earnings (accumulated deficit)(4,028)(4,223)(4,303)(3,880)(2,596)(3,966)99
Total stockholders' equity:(2,113)(2,420)(2,602)(2,343)(1,222)(2,763)1,313
TOTAL LIABILITIES AND EQUITY:17,41916,99016,29716,29018,38118,15720,652

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues7,0135,7394,0114,6377,3375,7165,076
Cost of revenue(2,871)(2,044)(1,797)(1,983)(2,776)(4,788)(2,224)
Gross profit:4,1423,6952,2142,6544,5629282,852
Operating expenses(3,630)(3,588)(2,612)(3,902)(5,054)(4,031)(3,007)
Operating income (loss):512107(398)(1,248)(492)(3,103)(155)
Nonoperating income (expense)(310)(21)(24)(31)1,903(35)(28)
Interest and debt expense(19)(21)(24)(31)(33)(35)(28)
Other undisclosed income from continuing operations before equity method investments, income taxes19212431333528
Income (loss) from continuing operations before income taxes:20286(422)(1,279)1,410(3,138)(183)
Income tax expense (benefit)(8)(6)(1)(5)(10)(927)40
Net income (loss) available to common stockholders, diluted:19480(423)(1,284)1,401(4,064)(142)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):19480(423)(1,284)1,401(4,064)(142)
Comprehensive income (loss), net of tax, attributable to parent:19480(423)(1,284)1,401(4,064)(142)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: